• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Bruce Cree Speaks About Relationship Between Managed Care Organizations and Subspecialists

Article

Dr. Bruce Cree, Assistant Professor of Clinical Neurology, Department of Neurology, University of California San Francisco, speaks to why he believes managed care organizations should provide an additional level of deference to the opinions of subspecialists over primary care physicians.

Dr. Cree states that he would like to see managed care organizations take recommendations from specialists to a higher degree. When a patient sees a subspecialst, as opposed to their PCP, they are receiving a different level of expertise.

Related Videos
Ivo Carre, PhD, senior business analyst, Lifescience Dynamics
Antonio Urbina, MD
Tina Bhatnagar, DO
Peter Voorhees, MD, Atrium Health Levine Cancer Institute
Antonio Urbina, MD
Ciara Zachary, PhD, MPH
Hearn Jay Cho, MD, PhD
Nicoletta Colombo, MD, PhD
Eleanor Perfetto, PhD
Related Content
Prerna Mewawalla, MD

Redesigning Trials for Real-World Patient Complexity: A Q&A With Prerna Mewawalla, MD

December 4th 2025
Article

Prerna Mewawalla, MD, discusses innovative strategies to enhance cancer care access, reduce clinician burden, and improve clinical trial diversity in real-world settings.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Dental Health Care Access

December 2nd 2025
Podcast

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.

Listen

The data showed that patients taking rituximab had higher rates of all-cause hospitalization compared to those taking ocrelizumab. | Image credit: Vitalii Vodolazskyi - stock.adobe.com

Ocrelizumab Leads to Lower Hospitalization Rates vs Rituximab in MS

November 26th 2025
Article

New research comparing the safety profiles of the 2 multiple sclerosis therapies suggests ocrelizumab is associated with lower rates of all-cause hospitalization and hypogammaglobulinemia.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

AJMC Q&A with Svetlana Barbarash | Background image credit: ipopba – stock.adobe.com

Women’s Subtle Arrhythmia Symptoms Are Often Overlooked: Svetlana Barbarash, MD

November 24th 2025
Article

Svetlana Barbarash, MD, explains how better education, digital monitoring tools, and coordinated care can improve arrhythmia detection and outcomes.

Read More

Mark Lebwohl, MD

Urticaria Symptoms, Sleep Improve With Remibrutinib: Mark Lebwohl, MD

November 20th 2025
Article

Urticaria symptom reduction with remibrutinib was linked with improved quality of life and sleep for patients with chronic spontaneous urticaria.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.